Mendez LC - Search Results

1

An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation.

Slevin F, Aitken K, Alongi F, Arcangeli S, Chadwick E, Chang AR, Cheung P, Crane C, Guckenberger M, Jereczek-Fossa BA, Kamran SC, Kinj R, Loi M, Mahadevan A, Massaccesi M, Mendez LC, Muirhead R, Pasquier D, Pontoriero A, Spratt DE, Tsang YM, Zelefsky MJ, Lilley J, Dickinson P, Hawkins MA, Henry AM, Murray LJ. Slevin F, et al. Among authors: mendez lc. Radiother Oncol. 2021 Nov;164:104-114. doi: 10.1016/j.radonc.2021.09.010. Epub 2021 Sep 21. Radiother Oncol. 2021. PMID: 34560186

2

The Role of Stereotactic Ablative Body Radiotherapy in Gynaecological Cancers: A Systematic Review.

Mendez LC, Leung E, Cheung P, Barbera L. Mendez LC, et al. Clin Oncol (R Coll Radiol). 2017 Jun;29(6):378-384. doi: 10.1016/j.clon.2017.01.009. Epub 2017 Feb 14. Clin Oncol (R Coll Radiol). 2017. PMID: 28209456 Review.

3

Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapy.

Mendez LC, Ravi A, Chung H, Tseng CL, Wronski M, Paudel M, McGuffin M, Cheung P, Loblaw A, Morton G. Mendez LC, et al. Brachytherapy. 2018 Mar-Apr;17(2):291-297. doi: 10.1016/j.brachy.2017.10.001. Epub 2017 Nov 11. Brachytherapy. 2018. PMID: 29137956

4

Absolute percentage of biopsied tissue positive for Gleason pattern 4 disease (APP4) appears predictive of disease control after high dose rate brachytherapy and external beam radiotherapy in intermediate risk prostate cancer.

Martell K, Mendez LC, Chung H, Tseng CL, Zhang L, Alayed Y, Liu S, Vesprini D, Chu W, Paudel M, Cheung P, Szumacher E, Ravi A, Loblaw A, Morton G. Martell K, et al. Among authors: mendez lc. Radiother Oncol. 2019 Jun;135:170-177. doi: 10.1016/j.radonc.2019.03.007. Epub 2019 Mar 27. Radiother Oncol. 2019. PMID: 31015164

5

Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.

Raziee H, D'Souza D, Velker V, Barnes E, Taggar A, Mendez L, Leung E. Raziee H, et al. Clin Oncol (R Coll Radiol). 2020 Jan;32(1):43-51. doi: 10.1016/j.clon.2019.07.015. Epub 2019 Aug 8. Clin Oncol (R Coll Radiol). 2020. PMID: 31402286

6

Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients.

Martell K, Mendez LC, Chung HT, Tseng CL, Alayed Y, Cheung P, Liu S, Vesprini D, Chu W, Wronski M, Szumacher E, Ravi A, Loblaw A, Morton G. Martell K, et al. Among authors: mendez lc. Radiother Oncol. 2019 Dec;141:149-155. doi: 10.1016/j.radonc.2019.08.017. Epub 2019 Sep 12. Radiother Oncol. 2019. PMID: 31522882

7

Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic.

Mendez LC, Raziee H, Davidson M, Velker V, D'Souza D, Barnes E, Leung E. Mendez LC, et al. Radiother Oncol. 2020 Jul;148:270-273. doi: 10.1016/j.radonc.2020.05.032. Epub 2020 May 28. Radiother Oncol. 2020. PMID: 32474128 Free PMC article.

8

Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?

Zhang TW, Palma D, D'Souza D, Velker V, Mendez LC. Zhang TW, et al. Among authors: mendez lc. Curr Treat Options Oncol. 2020 Jun 12;21(7):58. doi: 10.1007/s11864-020-00748-6. Curr Treat Options Oncol. 2020. PMID: 32533272 Review.

9

Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada.

Corkum MT, Morton G, Louie AV, Bauman GS, Mendez LC, Chin J, D'Souza DP, Dinniwell RE, Velker VM, Saskin R, Warner A, Rodrigues GB. Corkum MT, et al. Among authors: mendez lc. Radiother Oncol. 2020 Nov;152:42-48. doi: 10.1016/j.radonc.2020.07.036. Epub 2020 Jul 24. Radiother Oncol. 2020. PMID: 32717361

10

Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis.

Mendez LC, Loblaw A, Chung HT, Tseng CL, Ravi A, Morton G. Mendez LC, et al. Radiother Oncol. 2021 Jan;154:118-122. doi: 10.1016/j.radonc.2020.09.023. Epub 2020 Sep 20. Radiother Oncol. 2021. PMID: 32966843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page